Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06064006 · ClinicalTrials.gov registry record · Phase 2
A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the Skin
A Phase 2 study, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- Phase 2
- Development phase
- 125
- Enrollment target
NCT06064006 is a Phase 2 study that has completed, run by Novo Nordisk A/S. The registered enrollment target is 125 participants.
The verdict
NCT06064006, a Phase 2 study, has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 125 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate if a new study drug, NNC0487-0111, is safe and how it works in the participant's body, when given as injections under the skin
Interventions
- DRUG NNC0487-0111
- DRUG Placebo (NNC0487-0111)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2023-09-15 |
| Est. Completion | 2024-11-27 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06064006
The ClinicalTrials.gov registry entry for NCT06064006 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NNC0487-0111 is the first listed.
NCT06064006 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06064006 about?
NCT06064006 is a clinical study titled "A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the Skin". The purpose of the study is to evaluate if a new study drug, NNC0487-0111, is safe and how it works in the participant's body, when given as injections under the skin
What is the current status of trial NCT06064006?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 125 participants. The study started on 2023-09-15. Estimated completion is 2024-11-27.
What interventions are being tested in trial NCT06064006?
The interventions under investigation include: NNC0487-0111 (DRUG), Placebo (NNC0487-0111) (DRUG).
Who is sponsoring clinical trial NCT06064006?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.